Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses

Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses

Clinical trials on the use of COVID-19 convalescent plasma remain inconclusive. While data on safety is increasingly available, evidence for efficacy is still sparse. Subgroup analyses hint to a dose-response relationship between convalescent plasma neutralizing antibody levels and mortality. In par...

Full description

Bibliographic Details
Main Authors:	Stephan Schlickeiser, Tatjana Schwarz, Sophie Steiner, Kirsten Wittke, Nabeel Al Besher, Oliver Meyer, Ulrich Kalus, Axel Pruß, Florian Kurth, Thomas Zoller, Martin Witzenrath, Leif Erik Sander, Marcel A. Müller, Carmen Scheibenbogen, Hans-Dieter Volk, Christian Drosten, Victor M. Corman, Leif G. Hanitsch
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-01-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 SARS-CoV-2 immunodeficiency antibody deficiency coronavirus disease 2019 convalescent plasma
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.628971/full

Similar Items

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology
by: Sophie Steiner, et al.
Published: (2021-07-01)

The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised
by: Desiree J. Wendering, et al.
Published: (2019-02-01)

HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients
by: Sophie Steiner, et al.
Published: (2020-12-01)

Planning for convalescence with General Hospital patients : an analysis of the problems of patients requiring convalescence, and the social work services provided, based on a group of cases from the Vancouver General Hospital, 1954
by: Ellis, Jack Arthur Nixon
Published: (2012)

Assessment of nursing care-associated predictors of in-hospital mortality in the patients with acute ischemic stroke
by: Škodrić Angelina, et al.
Published: (2019-01-01)

Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects
by: Hong Lei, et al.
Published: (2019-11-01)

SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients
by: Tatjana Schwarz, et al.
Published: (2021-03-01)

Field Trial on 5G New Radio Over Satellite
by: Florian Völk, et al.
Published: (2021-06-01)

Aging Blepharoplasty
by: Inchang Cho
Published: (2013-09-01)

Gaussian Doubling Times and Reproduction Factors of the COVID-19 Pandemic Disease
by: Martin Kröger, et al.
Published: (2020-07-01)

A Gaussian Model for the Time Development of the Sars-Cov-2 Corona Pandemic Disease. Predictions for Germany Made on 30 March 2020
by: Reinhard Schlickeiser, et al.
Published: (2020-05-01)

Immunomodulatory Effects of Mesenchymal Stromal Cells Revisited in the Context of Inflammatory Cardiomyopathy
by: Kapka Miteva, et al.
Published: (2013-01-01)

Korean version of the convalescence and recovery evaluation: translation and linguistic validation
by: Hyeong Dong Yuk, et al.
Published: (2020-12-01)

Breakdown in membrane asymmetry regulation leads to monocyte recognition of P. falciparum-infected red blood cells.
by: Merryn Fraser, et al.
Published: (2021-02-01)

Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis
by: Eva Schrezenmeier, et al.
Published: (2021-06-01)

Covid-19 Predictions Using a Gauss Model, Based on Data from April 2
by: Janik Schüttler, et al.
Published: (2020-06-01)

The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes.
by: Katrin Witte, et al.
Published: (2015-01-01)

Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.
by: Madlen Loebel, et al.
Published: (2014-01-01)

Potential predictors of outcomes among hospitalized COVID-19 patients treated with convalescent plasma: a single-center study
by: Sridhar Chilimuri, et al.
Published: (2021-07-01)

Challenges in the collection of convalescent plasma for COVID-19 patients at a plasma therapy trial site
by: Nidhi Bhatnagar, et al.
Published: (2020-01-01)

Convalescent Plasma Transfusion for the Treatment of COVID-19—Experience from Poland: A Multicenter Study
by: Anna Moniuszko-Malinowska, et al.
Published: (2021-12-01)

Convalescent Plasma: An Old Trick for the Treatment of COVID-19
by: Reza Jafari, et al.
Published: (2020-07-01)

Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
by: Arturo Casadevall, et al.
Published: (2021-06-01)

Rapid Clinical and Radiological Improvement in a Patient with Severe COVID-19 Infection Treated with Convalescent Plasma
by: Stephen Malnick, et al.
Published: (2021-05-01)

Convalescent plasma: A potential therapeutic option for COVID-19 patients
by: Swee Li Ng, et al.
Published: (2020-01-01)

Cyclosporine A but Not Corticosteroids Support Efficacy of Ex Vivo Expanded, Adoptively Transferred Human Tregs in GvHD
by: Sybille Landwehr-Kenzel, et al.
Published: (2021-10-01)

Epidemics Forecast From SIR-Modeling, Verification and Calculated Effects of Lockdown and Lifting of Interventions
by: R. Schlickeiser, et al.
Published: (2021-01-01)

Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
by: Madlen Loebel, et al.
Published: (2017-01-01)

Usefulness of convalescent plasma transfusion for the treatment of severely ill COVID-19 patients in Pakistan
by: Tehmina Nafees Sonia Khan, et al.
Published: (2021-09-01)

Analytical Modeling of the Temporal Evolution of Epidemics Outbreaks Accounting for Vaccinations
by: Reinhard Schlickeiser, et al.
Published: (2021-05-01)

The Convalescent Plasma Craze! Where Does India Stand?
by: Arcot J. Priyadarsini, et al.
Published: (2021-06-01)

Relationship between the state of tongue hygiene and the number of residual teeth in convalescent-ward inpatients, cross- sectional study
by: Kanako Hayashi, et al.
Published: (2019-08-01)

COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors
by: Brett Ragnesola, et al.
Published: (2020-08-01)

The Life of Understanding
by: Tsutomu Ben Yagi
Published: (2014-06-01)

Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial
by: F.W. Hamilton, et al.
Published: (2021-08-01)

Response to convalescent plasma is not influenced by patient blood type
by: William R Hartman, et al.
Published: (2021-01-01)

Effects of adding convalescent plasma therapy for treatment of COVID-19 patients with severe and critical symptoms: a descriptive study of 12 cases
by: Shahnaz Sali, et al.
Published: (2021-06-01)

Evaluation of the patients with Grave’s ophthalmopathy after the corticosteroids treatment
by: Janićijević-Petrović Mirjana, et al.
Published: (2012-01-01)

Convalescent Plasma Therapy: An Effective Therapeutic Option to Treat COVID-19? A Narrative Review
by: Ray I, et al.
Published: (2020-10-01)

Individual Effector/Regulator T Cell Ratios Impact Bone Regeneration
by: Claudia Schlundt, et al.
Published: (2019-08-01)